As data volumes continue to skyrocket, edge computing is emerging as a crucial shift in how biotech enterprises build and operate their infrastructure. The combination of cloud and edge computing is revolutionizing real-time intelligence, enabling organizations to achieve unmatched speed, lower latency, and localized action.
With global spending on edge computing projected to reach nearly $380 billion by 2028, the momentum behind edge adoption shows no signs of slowing down. From manufacturing to healthcare to banking, the implementation of edge computing technology is transforming the way artificial intelligence operates, creating new opportunities for applications that require low-bandwidth and low-latency operations. Organizations in the biotech industry that embrace AI at the edge are poised to derive actionable insights locally and drive innovation where it matters most.
Read more on thefastmode.com